University of Medicine and Pharmacy "Grigore T. Popa"
Iași, 700115, Romania
NCT Number: NCT05705011
This observational study explores the impact of cognitive impairment and frailty in older adults with advanced chronic kidney disease ].
The main question[s] it aims to answer are:
* What determines the time to initiate dialysis? Cognitive impairment or frailty? * What does predict the time to death? Presence of frailty or cognitive impairment? * What does correlate strongly with time-low health-related quality of life? frailty or cognitive impairment?
Looking for future studies?
Notify Me65 year and older
All sexes
Observational
Iași, 700115, Romania
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 36 months
The time from the assessment moment to death of an older adult with advanced CKD ( CKD stage 4 and 5).
Time frame: 36 months
The time from the assessment moment to start dialysis of an older adult with advanced CKD (
Grigore T. Popa University of Medicine and Pharmacy
Other
Frailty, Cognitive Function and Health-related Quality of Life in Older Adults With Advanced Chronic Kidney Disease: Mortality and Dialysis Initiation, a Prospective Cohort Study.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05309785
CKD Stage 4, CKD Stage 5
Montreal, Quebec, Canada
View Trial DetailsNCT06795698
Anticoagulant-induced Bleeding, CKD Stage 3
Guadalajara, Jalisco, Mexico
View Trial DetailsNCT05514184
CKD Stage 3, CKD Stage 4
Orange, California, United States
View Trial DetailsNCT06094920
Albuminuria, CKD
Almelo, Overijssel, Netherlands
View Trial Details